HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Leukoencephalopathy in HTLV-I-associated myelopathy/tropical spastic paraparesis: MRI analysis and a two year follow-up study after corticosteroid therapy.

Abstract
Magnetic resonance imaging (MRI) of the brain was studied in 35 patients with HTLV-I-associated myelopathy (HAM)/tropical spastic paraparesis (TSP), 19 HTLV-I seropositive carriers without HAM/TSP (non-HAM/TSP carriers), 18 patients with HTLV-I seronegative spastic spinal paraparesis (SSP), and 82 HTLV-I seronegative controls with other neurological disorders. The incidence of white matter lesions was significantly higher in HAM/TSP (66%) than in the controls (23%) and SSP (11%). HAM/TSP exceeded non-HAM/TSP carriers significantly in the incidence of multiple white matter lesions (37% vs 10%). HAM/TSP affected the deep and subcortical cerebral white matter multifocally, sparing the periventricular regions. None of the lesions were enhanced by gadolinium-DTPA. HAM/TSP patients with the white matter lesions had both a longer duration of disease and a greater disability than did those without lesions. The white matter lesions gradually increased in number, as the disability status became worse, in spite of the high dose corticosteroid treatment. All these observations suggest that the MRI abnormalities of the HAM/TSP brain may reflect the chronic perivascular inflammation with progressive gliosis (chronic disseminated encephalomyelitis). We propose that brain MRI can be successfully utilized as a reliable and non-invasive measure for following the disease progression in HAM/TSP.
AuthorsJ Kira, K Fujihara, Y Itoyama, I Goto, K Hasuo
JournalJournal of the neurological sciences (J Neurol Sci) Vol. 106 Issue 1 Pg. 41-9 (Nov 1991) ISSN: 0022-510X [Print] Netherlands
PMID1779238 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • HTLV-I Antibodies
  • Prednisolone
  • Methylprednisolone
Topics
  • Age Factors
  • Brain (pathology)
  • Follow-Up Studies
  • HTLV-I Antibodies (blood)
  • HTLV-I Infections (pathology)
  • Human T-lymphotropic virus 1
  • Humans
  • Incidence
  • Magnetic Resonance Imaging
  • Methylprednisolone (therapeutic use)
  • Muscle Spasticity
  • Nervous System Diseases (pathology)
  • Paralysis (pathology)
  • Paraparesis, Tropical Spastic (drug therapy, pathology)
  • Prednisolone (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: